Comment on Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial. [J Clin Oncol. 2017]
Bevacizumab in small cell lung cancer / Roviello, Giandomenico; Sobhani, Navid; Generali, Daniele. - In: ANNALS OF TRANSLATIONAL MEDICINE. - ISSN 2305-5839. - 5:(2017), pp. "-"-"-". [10.21037/atm.2017.06.44]
Bevacizumab in small cell lung cancer
Roviello, Giandomenico;
2017
Abstract
Comment on Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial. [J Clin Oncol. 2017]
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Roviello G Bevacizumab in SCLC.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
107.57 kB
Formato
Adobe PDF
|
107.57 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
